Leveraged Commentary and Data’s (LCD) credit data, news, and research are now on PitchBook.
Learn more »
Latest Deal Type
AxonDx General Information
Developer of a circulating tumor cells detection device designed to scan all nucleated cells in a blood sample. The company's device scans un-enriched blood samples in minutes, finds all classes of circulating tumor cells shed by solid tumors, and offers a morphological and outsourced molecular characterization of positive cells, enabling cancer patients to self-diagnose early-stage cancer.